期刊
WORLD JOURNAL OF GASTROENTEROLOGY
卷 14, 期 25, 页码 3968-3973出版社
BAISHIDENG PUBLISHING GROUP INC
DOI: 10.3748/wjg.14.3968
关键词
Gaucher disease; enzyme replacement treatment; substrate reduction treatment; gene therapy; liver fibrosis
Gaucher disease (GD) is an autosomal recessive disease which if undiagnosed or diagnosed late results in devastating complications. Because of the heterozygous nature of GD, there is a wide spectrum of clinical presentation. Clinicians should be aware of this rare but potentially treatable disease in patients who present with unexplained organomegaly, anemia, massive splenomegaly, ascites and even cirrhosis of unknown origin. The treatment options for adult type GD include enzyme replacement treatment (ERT) and substrate reduction treatment (SRT) depending on the status of the patient. Future treatment options are gene therapy and smart molecules which provide specific cure and additional treatment options. In this review, we present the key issues about GD and new developments that gastroenterologists should be aware Of. (C) 2008 The WJG Press. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据